MSFT trades at ~$350 with P/E ~21, forward P/E ~18, PEG under 1, RSI under 30, while still growing revenue and earnings mid-to-high teens. These valuation metrics are historically low for a company of MSFT’s quality and growth, suggesting the market is overreacting to AI capex concerns. A re-rating is likely once sentiment shifts. Buying MSFT at current levels offers a strong risk/reward for patient value investors, as the company’s moat (Azure, enterprise software) ensures it will benefit regardless of which AI players win. Broader market correction could push the stock lower in the short term; AI capex overspending may continue to weigh on margins; earnings growth could decelerate.
MSFT trades at ~$350 with P/E ~21, forward P/E ~18, PEG under 1, RSI under 30, while still growing revenue and earnings mid-to-high teens. These valuation metrics are historically low for a company of MSFT’s quality and growth, suggesting the market is overreacting to AI capex concerns. A re-rating is likely once sentiment shifts. Buying MSFT at current levels offers a strong risk/reward for patient value investors, as the company’s moat (Azure, enterprise software) ensures it will benefit regardless of which AI players win. Broader market correction could push the stock lower in the short term; AI capex overspending may continue to weigh on margins; earnings growth could decelerate.